SENSEX NIFTY

Usfda

May 02, 2016 at 14:44 | Source: Moneycontrol.com
The company has announced that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for Metformin Hydrochloride extended-release tablets USP 500 mg and 750 mg.
May 02, 2016 at 14:02 | Source: Moneycontrol.com
Marksans Pharma announced that USFDA has granted approval for an ANDA for Metformin Hydrochloride extended-release tablets USP 500 mg and 750 mg.
May 02, 2016 at 13:32 | Source: PTI
"The company has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg," Alembic Pharmaceuticals said in a BSE filing.
Apr 29, 2016 at 14:08 | Source: PTI
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg," Aurobindo Pharma said in a filing on BSE.
Apr 29, 2016 at 12:46 | Source: PTI
"Glenmark Pharmaceuticals, USA, has been granted tentative approval by the US Food and Drug Administration (USFDA) for adapalene and benzoyl peroxide gel, 0.1 percent/ 2.5 percent," it said in a BSE filing today.
Apr 28, 2016 at 09:54 | Source: PTI
The tablets in the strength of 80 mg are made by Torrent for its US arm Torrent Pharma Inc, the latest US Food and Drug Administration (USFDA) enforcement report said.
Apr 28, 2016 at 09:52 | Source: PTI
Citing a number of issues, including quality control, the US health regulator said it "may withhold approval of any new applications or supplements listing your firm as drug manufacturer" till corrections were made by the company which has been placed on import alert on September 11, 2015.
Apr 27, 2016 at 12:36 | Source: PTI
Aurobindo Pharma today said it has received final approval from the US health regulator tomanufacture and market generic version of heartburn relief medicine Famotidine tablets.
Messages on Usfda »

boc

New Member

0 Follower

Divis Labs  

Be cautious while dealing with USFDA hammered stocks .......... I want to share my experience here, might be useful for some one of my kind.....................Similar thing was happened with DR Reddys Labs in Nov 2015. Rs4292 (6th Nov 2015) has become Rs 2750 by 21st Jan 2016, (lost 37%) because

9.53 PM Jan 23rd

sendtork

New Member

49 Followers

Sun Pharma  

Friends, today it raised my suspicion on the counter of Divis Lab. I think now it is very risky to trade in Divis Lab on the grounds of its constant falling and serious allegations by USFDA . Dimiliarly, in Dr. Datson lab it`s share price fell from the range of Rs.700-800 now under Rs.10

6.16 PM Jan 23rd

kdsamkds

New Member

1 Followers

Divis Labs  

Divis seems to be extremely incompetent. Cannot even burn incriminating documents properly. USFDA recovered them from the incinerator.

6.14 PM Jan 23rd

kalpataru70

Platinum Member

498 Followers

Aurobindo Pharm  

in 2015-16 total 40 usfda approal made to aurobindo pharma during 2016-17 total 15 usfda approval so far .market cap of the 55 products is around exceeding 1 lac crores. there will be revenue jump of more than 100% from 2018-19

3.19 PM Jan 23rd

cindrella20
04

Platinum Member

1869 Followers

Unichem Labs  

Despite the unfavorable global conditions USFDA issues plaguing the pharma sector and the threat of price control on domestic pharma prices,UNICHEM has posted good results for the 3rd quarter.This raises the hope of complete turnaround in future on the margins front(i mean NPM when i say margins

3.11 PM Jan 23rd

nick7

Platinum Member

1274 Followers

Divis Labs  

guys 695 too is broken...this stock is not following any technical patterns..lets be clear about it..its completely news driven now and stock can rise only if some positives from USFDA...till then it will get beaten on every rise... Regards,

2.28 PM Jan 23rd

Divis Labs  

better sell....less chances of recovery due to protracted usfda process, better sell

2.08 PM Jan 23rd

kk16011977

New Member

17 Followers

Divis Labs  

guys whatever calls i gave last week on divis was spot.. dont buy till usfda clears all charges and also trump administration policy is clear.. its high risk to buy now as 500 also possible on thia counter.. 600 is almost certain

1.21 PM Jan 23rd

venkatarao2
014

New Member

0 Follower

Natco Pharma  

is this usfda effect?

12.45 PM Jan 23rd

ap2109

New Member

4 Followers

Aurobindo Pharm  

Aurobindo is good foe long term. management strong. Already pass USFDA.

12.39 PM Jan 23rd

News across the web »
Sep 02, 2016 at 17:44 | Source: FirstPost
Aug 26, 2016 at 18:38 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.